- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 251/26 - Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
Patent holdings for IPC class C07D 251/26
Total number of patents in this class: 45
10-year publication summary
|
4
|
2
|
3
|
4
|
2
|
2
|
1
|
1
|
2
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shinryo Corporation | 74 |
4 |
| Crossing SRL | 10 |
4 |
| Centaurus Biopharma Co., Ltd. | 82 |
3 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 697 |
3 |
| Lianyungang Runzhong Pharmaceutical Co., Ltd. | 84 |
3 |
| Bayer Cropscience AG | 2042 |
2 |
| Sumitomo Chemical Company, Limited | 9040 |
2 |
| The United States of America as represented by the Secretary of the Navy | 2747 |
2 |
| Shimadzu Corporation | 6155 |
2 |
| Nippon Kasei Chemical Company Limited | 17 |
2 |
| Shizuoka Prefecture Public University Corporation | 18 |
2 |
| Novartis AG | 10867 |
1 |
| Janssen Pharmaceutica N.V. | 3399 |
1 |
| The Board of Trustees of the University of Illinois | 2689 |
1 |
| Agios Pharmaceuticals, Inc | 216 |
1 |
| Betta Pharmaceuticals Co., Ltd. | 179 |
1 |
| Corden Pharma International GmbH | 15 |
1 |
| National Chi Nan University | 23 |
1 |
| National University Corporation Nagoya University | 859 |
1 |
| Progenics Pharmaceuticals, Inc. | 130 |
1 |
| Other owners | 7 |